Genentech Withdraws Psoriasis Drug Linked to Brain Infections - Bloomberg.com

Genentech Withdraws Psoriasis Drug Linked to Brain Infections - Bloomberg.com: "Genentech Inc. began pulling its psoriasis treatment Raptiva from the U.S. market because of the drug’s link to a rare, fatal brain disorder that has troubled at least four other medicines." [Bloomberg.com]

Psoriasis Drug Raptiva Pulled From U.S. Market - Forbes.com

Psoriasis Drug Raptiva Pulled From U.S. Market - Forbes.com: "The troubled psoriasis drug Raptiva is being withdrawn from the U.S. market, California-based drug maker Genentech ( DNA - news - people ) announced Wednesday.

The move comes almost two months after U.S. health officials issued a public health advisory on the drug after confirming a link to a rare, sometimes fatal brain infection." [Forbes]

Raptiva is withdrawn from the U.S. market - UPI.com

Raptiva is withdrawn from the U.S. market - UPI.com: "The U.S. Food and Drug Administration says Genentech Inc. (NYSE:DNA) is withdrawing the psoriasis drug Raptiva and it will no longer be available in the United States.

The FDA said the company is taking the action because of a potential risk of patients developing progressive multifocal leukoencephalopathy -- a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system." [UPI]

Genentech Starts Pulling Back Psoriasis Drug - NYTimes.com

Genentech Starts Pulling Back Psoriasis Drug - NYTimes.com: "Genentech announced on Wednesday a phased voluntary withdrawal of the psoriasis drug Raptiva from the United States because of a link to a brain infection.

Raptiva has been associated with an increased risk of progressive multifocal leukoencephalopathy, a rare and usually fatal disease of the central nervous system." [NYT]